Combined endovascular stent grafting and endoscopic injection of fibrin sealant for aortoenteric fistula complicating esophagectomy  by Mok, Vivian W.K. et al.
Combined endovascular stent grafting and
endoscopic injection of fibrin sealant for
aortoenteric fistula complicating esophagectomy
Vivian W. K. Mok, MBBS,a Albert C. W. Ting, MBBS, FRCS,a Simon Law, MS, FRCS,b Kam Ho
Wong, MBBS, FRCS,b Stephen W. K. Cheng, MS, FRCS,a and John Wong, PhD, FRACS, FACS
(Hon),b Hong Kong, China
A 67-year-old man with previous total gastrectomy and roux-en-Y esophagojejunostomy had hematemesis 4 weeks after
esophagectomy performed because of carcinoma of the esophagus. Investigation showed an aortojejunal fistula with a
thoracic aortic pseudoaneurysm. Endovascular stent grafting of the pseudoaneurysm, followed by endoscopic injection of
fibrin sealant for the fistula, was performed, and the infection was controlled with broad-spectrum antibiotic agents
together with drainage and daily irrigation of the pseudoaneurysm sac. The fistula subsequently healed. The patient
remained well 14 months after the procedure; follow-up computed tomograms at 12 months did not show any
pseudoaneurysm, and there was no evidence of reopening of the fistula. ( J Vasc Surg 2004;40:1234-7.)Aortoenteric fistula, although rare, is a well-recognized
complication after thoracic surgery. The classic clinical triad
includes midthoracic chest pain, sentinel arterial bleeding,
and fatal hemorrhage.1 Early diagnosis and prompt surgical
intervention before massive exsanguinating hemorrhage
are key to survival, as 60% of patients in whom aortoenteric
fistulas develop die within 6 hours after onset of bleeding.2
Even with surgical treatment, mortality and morbidity re-
main significant, because the operation involves hemosta-
sis, with major arterial reconstruction in an infected terri-
tory, and the need to control sepsis, with restoration of
alimentary tract continuity. Complicated staged proce-
dures are often required.
We describe a novel approach to management in a
patient with an aortojejunal fistula associated with thoracic
aortic pseudoaneurysm complicating esophageal resection,
with a combined endovascular and endoscopic approach.
To our knowledge, this is the first report of the use of
combined endovascular stenting and endoscopic injection
of fibrin sealant in management of an aortoenteric fistula.
CASE REPORT
A 67-year-old man, who 15 years before this admission
underwent total gastrectomy, splenectomy, and roux-n-Y
esophagojejunostomy to treat carcinoma of the stomach, now
had progressive dysphasia, and squamous cell carcinoma of the
mid-esophagus was diagnosed. Investigations did not reveal any
evidence of distant metastasis. Neoadjuvant chemoradiation
was initiated preoperatively, according to institutional protocol.
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1234Esophagectomy was then carried out through an upper midline
laparotomy and right posterolateral thoracotomy. The roux
loop of jejunum was brought up to the right thoracic cavity for
esophagojejunal anastomosis, to restore alimentary tract conti-
nuity. Postoperative meglumine diatrizoate (Gastrografin)
swallow did not demonstrate any anastomotic leak, and the
patient was discharged to home on postoperative day 13.
He returned again 2 weeks later with fresh hematemesis and
hypotension, and required resuscitation and subsequent mechan-
ical ventilation. Hemoglobin level was 8.8 g/dL. Urgent upper
endoscopy revealed fresh blood and clots in the brought-up jejunal
loop, with some blood oozing along the esophagojejunal anasto-
mosis. Computed tomograms (CT) revealed a pseudoaneurysm in
the descending thoracic aorta, with gas inside, compressing the
jejunal loop, compatible with an aortojejunal fistula (Fig 1, A).
In view of the patient’s critical condition, endovascular stent
grafting was performed to control the bleeding. The procedure
was carried out in the operating room, with the patient under
general anesthesia, with image guidance with a mobile C-arm
fluoroscopy. A Talent (Medtronic/AVE) thoracic stent-graft de-
vice, 32 mm in diameter 100 mm long, was introduced through
a transverse arteriotomy over the right common femoral artery and
deployed to cover the descending thoracic aortic pseudoaneurysm.
An intraoperative aortogram confirmed satisfactory positioning of
the endograft, with complete sealing of the pseudoaneurysm sac.
The operation lasted 1 hour, with blood loss of 50 mL.
The patient remained stable, with no more bleeding epi-
sodes after the stent-grafting procedure. A left posterolateral
thoracotomy was performed the next day to drain the infected
pseudoaneurysm sac, which measured 7 cm in diameter, and the
endograft was not exposed. After evacuation of clots and thor-
ough lavage of the sac, 2 latex drains were placed in the
pseudoaneurysm sac for drainage and subsequent irrigation.
Meglumine diatrizoate swallow performed afterward revealed a
fistula arising from the esophagojejunal anastomosis and ex-
tending into the pseudoaneurysm cavity over the left side of the
chest (Fig 2, A). This was confirmed at endoscopic reassess-
stula
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anastomosis leading into the pseudoaneurysm (Fig 3, A). Thus
esophagojejunal anastomotic leak was believed to be the pri-
mary event that led to mediastinal abscess formation and sub-
Fig 1. A, Computed tomography scan shows a pseudoa
gas (white arrow) inside, compressing the jejunal loop, co
scan obtained 1 year later shows no pseudoaneurysm in
infection or reopening of the aortojejunal fistula.
Fig 2. A, Radiograph with meglumine diatrizoate (Ga
esophagojejunal anastomosis, and extending to the lef
swallow obtained 2 months later shows no evidence of fisequent erosion distally into the descending thoracic aorta, andeventually to development of a thoracic aortic pseudoaneurysm.
Blood culture grew Candida albicans, and the tissue from the
pseudoaneurysm sac yielded both Candida organisms and lac-
tobacilli. Intravenous fluconazole and a succession of broad-
ysm (black arrow) in the descending thoracic aorta, with
ible with aortojejunal fistula. B,Computed tomography
descending thoracic aorta, and there is no evidence of
rafin) swallow shows a fistula (arrow) arising from the
ral cavity. B, Radiograph with meglumine diatrizoate
or contrast leak.neur
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esophagojejunal anastomosis was planned, but declined by the
patient. To enhance closure of the fistula, Tisseel (Baxter AG), a
fibrin sealant, was injected into the fistula tract endoscopically. A
total of four endoscopic sessions were carried out, 1 to 2 weeks
apart, with 2 to 5 mL injected each time. Meanwhile the patient
received total parenteral nutrition, and the pseudoaneurysm cavity
was irrigated with saline solution daily through the latex drains. A
closed continuous irrigation system was established, with contin-
uous saline solution infusion at 50mL/h into the pseudoaneurysm
sac through 1 of the latex drains, and the effluent was collected
through the other latex drain. Reassessment CTs during the hos-
pital stay did not show any mediastinal collection.
A meglumine diatrizoate swallow performed 2 months later
showed that the fistula had closed (Fig 2, B), which was confirmed
at endoscopic examination (Fig 3, B). The saline solution irrigation
was stopped, and the latex drains were gradually removed. The
patient was discharged 11 weeks after the stent-grafting procedure,
and could tolerate a normal diet. Life-long oral antibiotic therapy
(cephalexin, metronidazole, and fluconazole) was instituted. Sub-
sequent CT scans at 6 months and 1 year (Fig 1, B) after the
operation did not show any pseudoaneurysm, and there was no
evidence of infection or reopening of the aortojejunal fistula. The
patient remained well 14 months after the procedure.
DISCUSSION
Aortoenteric fistula complicating thoracic surgery is a
rare but lethal condition associated with significant mortal-
ity and morbidity.3,4 Apart from the need for thoracotomy,
proximal aortic cross-clamping, and possibly extracorporeal
Fig 3. A, Endoscopic assessment shows the fistula open
the pseudoaneurysm sac. Note latex drains placed in pseu
Endoscopic assessment 2 months later shows complete hbypass, major vascular reconstruction in an infected field,together with complex enteric diversion and reconstruction
procedures are often required. Although, esophagojejunal
anastomotic leak with mediastinal abscess was believed to
be the primary event, unrecognized iatrogenic injury of the
thoracic aorta at esophageal surgery in this patient who had
previously undergone radiation therapy may also have con-
tributed to development of a thoracic aortic pseudoaneu-
rysm.
Endovascular repair has been introduced as a less inva-
sive alternative to treat various thoracic aortic disorders,
including aneurysm,5 trauma,6 and dissection.7 Its use in
treating mycotic aneurysms is controversial because of the
concern of stent-graft infection. However, even with open
repair, in situ reconstruction is often unavoidable, and the
safety and durability of in situ reconstruction in the pres-
ence of aortic sepsis have been described.8 More recently,
successful endovascular stenting in treating mycotic tho-
racic aortic aneurysms has been reported.9
The situation in aortoenteric fistula is more compli-
cated in that endovascular repair alone fails because the
stent is in persistent contact with a septic environment
because of the presence of a fistula. This is well exemplified
by the report of a fatal complication in which an aorto-
esophageal fistula reopened after endovascular stenting
alone, and led to death from mediastinitis.10 Definitive
surgical treatment with esophagectomy after endovascular
repair had been advocated for management of the aorto-
esophageal fistula.11
We describe a novel approach in managing aortoenteric
fistula with endovascular stenting together with endoscopic
arrow) at the esophagojejunal anastomosis leading into
eurysm cavity are visible through the fistula opening. B,
g of the fistula at the esophago-jejunal anastomosis.ing (
doaninjection of fibrin sealant (Tisseel) to close the fistula. Fibrin
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a freeze-dried concentrate of clotting proteins, mainly fi-
brinogen, factor XIII, and fibronectin (the sealant), and
freeze-dried thrombin (the catalyst). Apart from hemosta-
sis, it is used to promote tissue sealing and wound heal-
ing.12 The use of fibrin sealant in treating thoracic esoph-
ageal anastomotic leak as well as complicated anal fistula has
been advocated.13,14 More recently its use in closing a
tracheoesophageal fistula has also been reported.15 Never-
theless, adequate control of sepsis remains important. We
controlled the infection with appropriate broad-spectrum
antibiotic agents together with drainage and daily irrigation
of the pseudoaneurysm sac. Life-long maintenance antibi-
otic therapy is being administered in view of the likely
contamination during implantation.
With potent antibiotic agents and a careful surveillance
program, combined endovascular stenting and endoscopic
injection of fibrin sealant appears to be a possible alternative
to conventional open surgery for management of aortoen-
teric fistulas. Although the long-term durability needs fur-
ther study and longer follow-up, this approach may be
considered a temporizing measure or as palliative treat-
ment, especially in patients at high risk.
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